글로벌 보조 생식 기술 ART 시장 – 2031년까지의 산업 동향 및 예측

보조 생식 기술 ART 시장 분석 및 규모

보조 생식 기술(ART) 시장은 불임률 증가, 기술 발전, ART 시술에 대한 인식 및 수용 증가와 같은 요인에 의해 상당한 성장을 경험하고 있습니다. 이 시장은 불임 치료를 추구하는 부부의 수 증가와 지연된 출산 추세가 증가하는 것이 특징입니다. 또한 불임에 영향을 줄 수 있는 다낭성 난소 증후군(PCOS) 및 자궁 내막증 과 같은 질환의 유병률 증가와 같은 요인이 시장 성장을 촉진하고 있습니다. 나아가 시험관 수정(IVF), 세포질 내 정자 주입(ICSI), 대리모와 같은 다양한 ART 시술의 가용성은 임신을 원하는 부부의 옵션을 확대하고 있습니다.

글로벌 보조 생식 기술 ART 시장 규모는 2023년에 284억 9천만 달러로 평가되었으며, 2031년까지 543억 2천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 8.4%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

Market Definition

Assisted Reproductive Technology (ART) refers to a range of medical procedures used to treat infertility. ART involves the manipulation of eggs, sperm, or embryos to help achieve pregnancy. Common ART procedures include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete intrafallopian transfer (GIFT). Assisted reproductive technologies (ARTs) are usually used to treat infertility when other methods of achieving pregnancy, such as medication or surgery, have not been successful. 

Assisted Reproductive Technology ART Market Dynamics

Drivers

• Increasing Infertility Rates

The prevalence of infertility is on the rise globally, fueled by various factors such as lifestyle changes, environmental factors, and age-related fertility issues. Modern lifestyles characterized by stress, unhealthy diet, and sedentary habits have contributed to hormonal imbalances and reproductive health issues, leading to an increase in infertility cases. Environmental factors such as exposure to pollutants and toxins can also negatively impact fertility. In addition, age-related fertility issues become more prevalent, with more couples choosing to start families later in life. These factors combined have led to a growing demand for ART procedures, driving market growth.    

• Delayed Parenthood   

Delayed parenthood has become increasingly common, driven by factors such as pursuing higher education, establishing careers, and financial stability. Many individuals and couples choose to delay starting a family until later in life, often in their 30s or even 40s. Although delaying parenthood offers benefits such as emotional maturity and financial security, it also presents challenges related to fertility. As individuals age, the quality and quantity of their eggs and sperm decrease, making conception more challenging. This has contributed to a growing demand for ART procedures among older individuals, as they seek assistance in overcoming age-related fertility issues and realizing their goal of starting a family, driving the market growth.

Opportunities

• Growing Awareness and Acceptance

There has been a significant increase in awareness about infertility treatments, with more individuals and couples seeking solutions to overcome fertility challenges. This growing awareness has been accompanied by a shift in societal attitudes towards ART, with more acceptance and understanding of these treatments as viable options for achieving pregnancy. As a result, there has been a notable increase in the number of couples seeking ART procedures. In addition, the recognition of male infertility as a significant factor in couples' inability to conceive has further fueled research and development efforts toward innovative treatments for male factor infertility, expanding the market opportunities.  

• Technological Advancements in ART  

There are continuous advancements in infertility art-assisted reproductive technology, leading to improved treatment outcomes and expanded options for patients. Technologies such as improved embryo culture techniques, genetic testing, and embryo selection methods have significantly enhanced the success rates of ART procedures. These advancements in embryo culture techniques have enhanced the monitoring and selection of embryos with the highest likelihood of successful implantation, thereby improving the overall success rates of IVF procedures. Similarly, genetic testing has enabled the screening of embryos for genetic abnormalities, reducing the risk of miscarriage and improving the chances of a successful pregnancy. These technological advancements have not only improved the effectiveness of ART procedures but have also expanded the treatment options available to patients, driving market growth.

Restraints/Challenges

• High Cost of ART Procedures 

The expenses involved in ART can quickly add up, making it unaffordable for some individuals and couples. Factors contributing to the high cost of ART include the need for specialized medical equipment, laboratory procedures, and highly trained personnel. In addition, the cost of medications used in ART can be substantial, especially for hormone treatments required to stimulate ovulation. The financial burden of ART can be further exacerbated by the fact that success is not guaranteed, and multiple treatment cycles may be needed before achieving a successful pregnancy, leading to additional costs. As a result, the high cost of ART procedures remains a major challenge for many individuals and couples seeking infertility treatment. 

• Health Risks in ART procedures

ART procedures can carry health risks for both the mother and the child, which need to be carefully considered before undergoing treatment. One of the primary risks associated with ART is the increased likelihood of multiple pregnancies, which can result in complications such as premature birth, low birth weight, and other health issues for both the mother and the babies.  Women who undergo ART procedures face the risk of developing ovarian hyperstimulation syndrome (OHSS), which is characterized by enlarged and painful ovaries. While OHSS is usually mild, severe cases can lead to complications such as fluid buildup in the abdomen and chest, blood clots, and kidney failure. While assisted reproductive technology is an infertility treatment, the potential health risks associated with these procedures can be a challenge for market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the assisted reproductive technology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In July 2021, Hamilton Throne Ltd., a worldwide leader in ART research, completed the acquisition of IVFTECH ApS (IVFtech) and its affiliated company, K4 Technology ApS. IVFtech specializes in supplying laminar flow workstations and high-capacity incubators for ART, leveraging the expertise of its affiliated firm, K4. The transaction was valued at USD 8 million
• In September 2020, Assisted Reproductive Technology ART bill was introduced in Lok Sabha. the Bill aims to regulate Assisted Reproductive Technology (ART) services in India. ART encompasses all techniques that aim to achieve pregnancy by manipulating sperm or oocytes outside the body and transferring the gamete or embryo into a woman's reproductive system. Instances of ART services include gamete donation, in-vitro fertilisation (fertilising an egg in a lab), and gestational surrogacy (where the child is not biologically related to the surrogate mother). ART services will be provided through ART clinics, which offer related treatments and procedures, and ART banks, which store and supply gametes

Assisted Reproductive Technology ART Market Scope

The market is segmented on the basis of procedure, technology, product type, and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Procedure

• Fresh Donor
• Fresh Nondonor
• Frozen Donor
• Frozen Nondonor
• Embryo/Egg Banking

Technology

• In-vitro Fertilization (IVF)
  • IVF with Intracytoplasmic Sperm Injection (ICSI)
  • IVF without ICSI
• Artificial Insemination - Intrauterine Insemination (AI-IUI)
• Frozen Embryo Replacement (FER)
• Surrogacy
• Ovulation Induction
• Others

 Product Type

• Women Younger Than Age 35
• Women Older Than Age 35

 End Use

• Hospitals
• Fertility Clinics
• Others

Assisted Reproductive Technology ART Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, procedure, technology, product type, and end-use as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to a combination of rising infertility rates and a heightened awareness of available fertility treatments. The region's well-established healthcare infrastructure, coupled with high disposable income, enables greater access to and adoption of ART procedures. In addition, the presence of leading ART clinics and research facilities further helps the market growth in the region.

Asia-Pacific is expected to witness significant growth during the forecast period due to several factors, including the increasing trend of late family planning adoption, where couples are choosing to have children at a later age, leading to a higher demand for ART services. Moreover, the relatively lower costs of ART treatments in the Asia-Pacific region compared to other parts of the world make these services more accessible to a broader population. The region's improving healthcare infrastructure and advancements in ART technologies also contribute to its growth.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

의료 인프라 성장 설치 기반 및 신기술 침투

보조 생식 기술 ART 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 보조 생식 기술 ART 시장을 위한 다양한 종류의 제품 설치 기반, 생명선 곡선을 사용하는 기술의 영향, 의료 규제 시나리오의 변화 및 보조 생식 기술 ART 시장에 미치는 영향. 이 데이터는 2016-2021년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 보조 생식 기술 ART 시장 점유율 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• 캘리포니아 크라이오뱅크(미국)
• 블룸 생식 센터(인도)
• 아네코바(스위스)
• 쿠퍼서지컬(미국)
• 머크 KGaA(독일)
• 페링 BV(스위스)
• FUJIFILM Irvine Scientific(미국)
• 제네아 리미티드(호주)
• 니다콘 인터내셔널 AB(스웨덴)
• 셀매틱스 주식회사(미국)
• 에스코 마이크로 Pte Ltd. (싱가포르)
• INVO Bioscience (미국)
• Laboratoire CCD(프랑스)
• Nikon Instruments Inc. (미국)
• ICU Medical, Inc. (미국)

SKU-51909